<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="178303">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00773942</url>
  </required_header>
  <id_info>
    <org_study_id>HHSA290200500381 T02</org_study_id>
    <secondary_id>HHSA290200500381 T02</secondary_id>
    <nct_id>NCT00773942</nct_id>
  </id_info>
  <brief_title>Design &amp; Evaluation of a Medication Therapy Management Program to Improve Patient Safety in Medicare Beneficiaries</brief_title>
  <official_title>Design &amp; Evaluation of a Medication Therapy Management Program to Improve Patient Safety in Medicare Beneficiaries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Illinois at Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Agency for Healthcare Research and Quality (AHRQ)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Baylor Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>RTI International</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Illinois at Chicago</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if a medication therapy management program
      designed to reconcile a patient's medications and identify and resolve drug related problems
      can reduce adverse drug events and other measures of safety and improve patient
      satisfaction.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">September 2009</completion_date>
  <primary_completion_date type="Actual">September 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single Blind (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adverse Drug Events</measure>
    <time_frame>3 and 6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Emergency department visits</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalizations</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Drug related problems</measure>
    <time_frame>3 and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Discrepancies in medication list, intervention arms compared with best possible medication history</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction with care.</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">637</enrollment>
  <condition>Chronic Illness</condition>
  <condition>Adverse Effects</condition>
  <condition>Medication Errors</condition>
  <condition>Elderly Patients</condition>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Study subjects receive usual care, without the intervention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Basic medication therapy management</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects in this arm will receive medication reconciliation and drug related problem assessment by a medication therapy management clinician utilizing patient interview alone.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Enhanced medication therapy management</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects in this arm will receive medication reconciliation and drug related problem assessment by a medication therapy management clinician utilizing patient interview and a brief chart synopsis including patient medical history, medication history, and relevant laboratory information.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Basic medication therapy management</intervention_name>
    <description>Subjects in this arm will receive medication reconciliation and drug related problem assessment by a medication therapy management clinician utilizing patient interview alone.</description>
    <arm_group_label>Basic medication therapy management</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Enhanced medication therapy management</intervention_name>
    <description>Subjects in this arm will receive medication reconciliation and drug related problem assessment by a medication therapy management clinician utilizing patient interview and chart information.</description>
    <arm_group_label>Enhanced medication therapy management</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Be at least 65 years old at enrollment

          -  Primarily uses English language for written and oral communication

          -  Have three or more comorbid conditions associated with increased healthcare
             utilization (Diabetes Mellitus, Congestive Heart Failure, Asthma, Hypertension,
             Dyslipidemia, COPD, Coronary Artery Disease, Chronic Renal Failure, Arthritis,
             Depression, Dementia, Chronic Pain, Conditions requiring anticoagulation with
             warfarin)

          -  Have visited a physician at one or more of the clinics on a regular basis (defined as
             two or more clinic visits over one year prior to the study start) for these
             conditions

          -  Have received 6 or more different chronic prescription medications over the six
             months prior to the enrollment period

          -  Have a telephone line and agree to maintain it for at least six months

          -  Have one of the following situations placing him/her at risk for a DRP (Any ER visit
             in past 30 days or Urgent Care visit in past 30 days leading to a change in
             medication or change in medication dose; New physician visit in past 30 days;
             Hospitalization in past 30 days; Invasive procedure (a procedure requiring
             substantive changes to medication taking practices or which requires informed
             consent) in past 30 days; Change in medication in past 30 days; Three or more
             providers seen in the past year

        Exclusion Criteria:

          -  Terminal condition, where life expectancy is less than 6 months

          -  Patients already enrolled in an MTM program where medication reconciliation and/or
             assessment of DRPs has occurred in the previous 12 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel R Touchette, PharmD, MA</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Illinois at Chicago</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Illinois at Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University Health System</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor Health Care System</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75206</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Masica AL, Touchette DR, Dolor RJ, Schumock GT, Kliethermes MA, Rodgers PT, Craft JL, Choi YK, Lux LJ, Smith SR. Evaluation of a Medication Therapy Management Program in Medicare Beneficiaries at High Risk of Adverse Drug Events: Study Methods. In: Henriksen K, Battles JB, Keyes MA, Grady ML, editors. Advances in Patient Safety: New Directions and Alternative Approaches (Vol. 4: Technology and Medication Safety). Rockville (MD): Agency for Healthcare Research and Quality (US); 2008 Aug.</citation>
    <PMID>21249958</PMID>
  </reference>
  <verification_date>October 2009</verification_date>
  <lastchanged_date>October 30, 2009</lastchanged_date>
  <firstreceived_date>October 15, 2008</firstreceived_date>
  <responsible_party>
    <name_title>Daniel R. Touchette/ Assistant Professor of Pharmacy Practice</name_title>
    <organization>University of Illinois at Chicago</organization>
  </responsible_party>
  <keyword>Medication therapy management</keyword>
  <keyword>Pharmacist</keyword>
  <keyword>Chronic care</keyword>
  <keyword>Medicare</keyword>
  <keyword>Medicaid</keyword>
  <keyword>Medication reconciliation</keyword>
  <keyword>Adverse drug events</keyword>
  <keyword>Drug related problems</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Chronic Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
